...pathway rather than a 510(k) application. Cytori was seeking approval of its Celution 700 and StemSource...

...18 months for use in translational medicine and stem cell banking in combination with Cytori's StemSource...

...tissue. Green Hospital Supply Inc. (Tokyo:3360, Osaka, Japan), which has Japanese rights to market CYTX's StemSource...

...Green Hospital received exclusive rights to market CYTX's StemSource cell bank in Japan. StemSource includes the...

...the remaining outstanding shares of stem cell company StemSource for 1.4 million shares of XMP. StemSource...
...adult stem cell-based therapeutics to degenerative and chronic conditions. MacroPore Biosurgery Inc. (FSE:XMP), Frankfurt, Germany StemSource Inc....